A new derivative of Texan is safer for effective treatment of lung cancer

 

A new derivative of Texan is safer for effective treatment of lung cancer – a drug with fewer side effects (Prof. Anwar Rayan, GS; Fund: Israel Cancer Association (ISA) Budget: 75,000 IS, Project Duration: two year).